PAR.NS
Par Drugs and Chemicals Limited [PAR.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PAR.NS Stock Summary
Top 10 Correlated ETFs
PAR.NS
Top 10 Correlated Stocks
PAR.NS
In the News
PAR.NS Financial details
Company Rating
-
Market Cap
3.04B
Income
142.29M
Revenue
966.59M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
105
Optionable
No
Shortable
Yes
Earnings
08 Apr 2024
P/E
20.54
Forward P/E
-
PEG
3.77
P/S
2.72
P/B
21.15
P/C
-
P/FCF
34.43
Quick Ratio
2.24
Current Ratio
4.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
11.57
EPS next Y
-
EPS next Q
-
EPS this Y
22.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
36.13%
Revenue last 5Y
15.84%
Revenue Q/Q
-7.29%
EPS Q/Q
-30.15%
-
-
-
-
SMA20
9.8%
SMA50
-44.65%
SMA100
-63.83%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
61%
ROC
0.21%
Gross Margin
33%
Oper. Margin
18%
Profit Margin
13%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
147.05-249.8
52W High
-60.08%
52W Low
-32.37%
RSI
44.41
Rel Volume
0.13
Avg Volume
37.16K
Volume
4.92K
Perf Week
-4.15%
Perf Month
0.58%
Perf Quarter
-68.11%
Perf Half Y
-66.81%
-
-
-
-
Beta
0.249
-
-
Volatility
2.62%, 5.46%
Prev Close
-2.67%
Price
99.41
Change
-5.31%
Company Profile
- Volume Average 37.16K
- Market Capitalization 3.04B
- Employee 105
- CEO Mr. Jignesh Vallabhbhai Savani
- Headquarters Vadodara,IN
- IPO Date 2019-05-30
-
Website
https://pardrugs.com 
Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
